Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERCC5 | P28715 | 7/20 | 1.00 |
| ▸ | FEN1 | P39748 | 7/20 | 1.00 |
| ▸ | HAO1 | Q9UJM8 | 6/20 | 1.00 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.60 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.60 |
| ▸ | GSK3B | P49841 | 1/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 1/20 | 0.58 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.56 |
| ▸ | CES1 | P23141 | 1/20 | 0.56 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1109671 | 0.87 | ERCC5 (1.00) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL27182280 | 0.87 | ERCC5 (0.77) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL27835156 | 0.85 | ERCC5 (0.95) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL27655689 | 0.85 | ERCC5 (0.95) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL27742318 | 0.85 | ERCC5 (0.95) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL30364011 | 0.85 | ERCC5 (0.95) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL10789985 | 0.85 | SMN1; SMN2 (0.77) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL27691553 | 0.85 | ERCC5 (0.95) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL27316384 | 0.85 | ERCC5 (0.95) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 | |
| SCHEMBL28005060 | 0.85 | ERCC5 (0.95) | ERCC5FEN1HAO1PTPN1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1082121-A4 | HIV INTEGRASE INHIBITORS | MERCK & CO INC (US) | 2003-02-05 | — | — | EP | claimed |
| EP-1082121-A1 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2001-03-14 | — | — | EP | claimed |
| WO-1999062520-A1 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 1999-12-09 | — | — | WO | claimed |
| EP-1082121-A4 | HIV INTEGRASE INHIBITORS | MERCK & CO INC (US) | 2003-02-05 | — | — | EP | disclosed |
| US-6380249-B1 | HIV integrase inhibitors | MERCK & CO., INC. | 2002-04-30 | — | — | US | disclosed |
| EP-1082121-A1 | HIV INTEGRASE INHIBITORS | Merck & Co., Inc. (US) | 2001-03-14 | — | — | EP | disclosed |
| WO-1999062520-A1 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 1999-12-09 | — | — | WO | disclosed |
| US-4336397-A | 2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis | MERCK & CO., INC. (US) | 1982-06-22 | — | — | US | disclosed |